PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.190
+0.040 (3.48%)
At close: Jun 26, 2026, 4:00 PM EDT
1.210
+0.020 (1.68%)
After-hours: Jun 26, 2026, 4:13 PM EDT
PMV Pharmaceuticals Employees
PMV Pharmaceuticals had 54 employees as of December 31, 2025. The number of employees increased by 7 or 14.89% compared to the previous year.
Employees
54
Change (1Y)
7
Growth (1Y)
14.89%
Revenue / Employee
n/a
Profits / Employee
-$1,450,815
Market Cap
63.46M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 54 | 7 | 14.89% |
| Dec 31, 2024 | 47 | -16 | -25.40% |
| Dec 31, 2023 | 63 | 1 | 1.61% |
| Dec 31, 2022 | 62 | 8 | 14.81% |
| Dec 31, 2021 | 54 | 10 | 22.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Acrivon Therapeutics | 76 |
| Seres Therapeutics | 66 |
| BeyondSpring | 44 |
| eXoZymes | 32 |
| Boundless Bio | 28 |
| Filana Therapeutics | 20 |
| Edesa Biotech | 17 |
| MiNK Therapeutics | 15 |
PMVP News
- 23 days ago - PMV Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 6 weeks ago - PMV Pharmaceuticals price target lowered to $5 from $6 at Oppenheimer - TheFly
- 6 weeks ago - PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c) - TheFly
- 6 weeks ago - PMV Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 6 weeks ago - PMV Pharmaceuticals Earnings release: Q1 2026 - Filings
- 2 months ago - PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed - TheFly
- 2 months ago - PMV Pharmaceuticals Announces Board Chair Transition - GlobeNewsWire
- 2 months ago - PMV Pharmaceuticals Proxy statement: Proxy filing - Filings